Asensus Surgical/ASXC

$0.31

1.66%
-
1D1W1MYTD1YMAX

About Asensus Surgical

Asensus Surgical, Inc. is a medical device company. The Company is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The Company is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.

Ticker

ASXC

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Anthony Fernando

Employees

183

Headquarters

Durham, United States

Asensus Surgical Metrics

BasicAdvanced
$79.3M
Market cap
-
P/E ratio
-$0.33
EPS
1.47
Beta
-
Dividend rate

What the Analysts think about Asensus Surgical

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 1 analysts.
545.16% upside
High $2.00
Low $2.00
$0.31
Current price
$2.00
Average price target

Asensus Surgical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,830% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$1M
0%
Net income
$-18.3M
-11.17%
Profit margin
-1,830%
-11.17%

Asensus Surgical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.08
-$0.09
-$0.09
-$0.07
-
Expected
-$0.08
-$0.08
-$0.08
-$0.07
-$0.08
Surprise
0%
12.5%
12.5%
0%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Asensus Surgical stock

Buy or sell Asensus Surgical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing